Chronic kidney outcomes associated with GLP-1 receptor agonists versus long-acting insulins among type 2 diabetes patients requiring intensive glycemic control: a nationwide cohort study
Effectiveness of glucagon-like peptide-1 receptor agonists (GLP-1RAs) versus long-acting insulins (LAIs) on preventing progressive chronic kidney outcomes is uncertain for type 2 diabetes (T2D) patients requir...
Source: Cardiovascular Diabetology - Category: Cardiology Authors: Zi-Yang Peng, Chun-Ting Yang, Wei-Hung Lin, Wen-Yu Yao, Huang-Tz Ou and Shihchen Kuo Tags: Research Source Type: research
More News: Cardiology | Cardiovascular | Diabetes | Diabetes Type 2 | Endocrinology | Heart | Study | Urology & Nephrology